effects of
serial treatment
doxorubicin
dynamic myocardial scintigraphy
[omega-I-131]heptadecanoic acid
I-131 HA
global left-ventricular function
echocardiographically
group
mongrel dogs
myocardial
lipid
postmortem
group
control dogs
doxorubicin-treated dogs
significant
progressive
fall
global
LV function
cumulative
doxorubicin
dose
increase
myocardial
I-131
HA
cumulative dose
alteration
myocardial lipids
control dogs
treated with
doxorubicin
findings
changes
alteration
myocardial dynamic imaging
I-131
HA
factor
doxorubicin
cardiotoxicity
